Insider Transactions in Q2 2021 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
14,194
-3.95%
|
$227,104
$16.32 P/Share
|
|
Jun 14
2021
|
Kristin Yarema Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
32,333
+11.06%
|
$452,662
$14.53 P/Share
|
|
Jun 11
2021
|
Kristin Yarema Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
2,021
+2.11%
|
$28,294
$14.5 P/Share
|
|
Jun 08
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,820
-3.41%
|
$81,480
$14.06 P/Share
|
|
Jun 08
2021
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+32.35%
|
-
|
|
Jun 08
2021
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+19.69%
|
-
|
|
Jun 08
2021
|
Eric Dobmeier |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+22.0%
|
-
|
|
Jun 08
2021
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+8.96%
|
-
|
|
Jun 08
2021
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jun 08
2021
|
Ronald C Renaud Jr |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jun 08
2021
|
William K Heiden |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+25.88%
|
-
|
|
Jun 08
2021
|
Beth C Seidenberg |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+22.36%
|
-
|
|
May 18
2021
|
Kristin Yarema Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
761
-0.82%
|
$10,654
$14.55 P/Share
|
|
May 18
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,616
-2.1%
|
$50,624
$14.55 P/Share
|
|
May 18
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
8,313
-2.26%
|
$116,382
$14.55 P/Share
|
|
May 18
2021
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,681
-5.83%
|
$79,534
$14.55 P/Share
|
|
May 18
2021
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
5,184
-5.18%
|
$72,576
$14.55 P/Share
|
|
May 18
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,453
-1.87%
|
$34,342
$14.55 P/Share
|
|
May 17
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,500
-2.59%
|
$52,500
$15.0 P/Share
|
|
Apr 05
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
655
-0.48%
|
$9,170
$14.74 P/Share
|